The Management of Behavioral and Psychological Symptoms of Dementia: The Need for Tailored Interventions

Journal of the American Medical Directors Association

Volumn 14, Issue 4, 2013, Pages 306-307

  Liperoti, Rosa ^a   Landi, Francesco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGGRESSION; AGITATION; ANXIETY; APATHY; BEHAVIOR DISORDER; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DEATH; DELUSION; DEMENTIA; DEPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HALLUCINATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSTITUTIONALIZATION; LETTER; MEDICAID; MEDICARE; MENTAL DISEASE; NURSING HOME; OFF LABEL DRUG USE; SLEEP DISORDER; TREATMENT RESPONSE; UNITED STATES;

EID: 84878015693     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.01.006     Document Type: Letter

References (20)

1. Liperoti R., Onder G., Landi F., et al. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: A retrospective cohort study. J Clin Psychiatry 2008, 70:1340-1347.
2. Ballard C., Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst Rev 2006, (1):CD003476.
3. Cohen-Mansfield J., Jensen B. Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: Self-reports of physicians' practices. J Am Med Dir Assoc 2008, 9:406-413.
4. Shorr R.I., Fought R.L., Ray W.A. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994, 271:358-363.
5. Mitka M. CMS seeks to reduce antipsychotic use in nursing home residents with dementia. JAMA 2012, 308:119-121.
6. Lindsley C.W. The top prescription drugs of 2011 in the United States: Antipsychotics and antidepressants once again lead CNS therapeutics. ACS Chem Neurosci 2012, 3:630-631.
7. Cohen C.A., Gold D.P., Shulman K.I., et al. Factors determining the decision to institutionalize dementing individuals: A prospective study. Gerontologist 1993, 33:714-720.
8. Franco K.N., Messinger-Rapport B. Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. J Am Med Dir Assoc 2006, 7:201-202.
9. Volicer L. Antipsychotics do not have to be used " off label" in dementia. J Am Med Dir Assoc 2012, 13:495-496.
10. Seitz D.P., Adunuri N., Gill S.S., et al. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev 2011, (2):CD008191.
11. Siddique H., Hyan L.S., Weiner M.F. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease. J Clin Psychiatry 2009, 70:915-918.
12. Bergh S., Selbæk G., Engedal K. Discontinuation of antidepressants in people with dementia and neuropsychiatric symptoms (DESEP study): Double blind, randomised, parallel group, placebo controlled trial. BMJ 2012, 344:e1566.
13. Fitzgerald S.P., Bean N.G. An analysis of the interactions between individual comorbidities and their treatments--implications for guidelines and polypharmacy. J Am Med Dir Assoc 2010, 11:475-484.
14. Liperoti R., Gambassi G., Lapane K.L., et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med 2005, 165:696-701.
15. Malhotra A.K., Zhang J.P., Lencz T. Pharmacogenetics in psychiatry: Translating research into clinical practice. Mol Psychiatry 2012, 17:760-769.
16. Cohen-Mansfield J., Thein K., Marx M.S., Dakheel-Ali M. What are the barriers to performing nonpharmacological interventions for behavioral symptoms in the nursing home?. J Am Med Dir Assoc 2012, 13:400-405.
17. Landi F., Liperoti R., Bernabei R. Postacute rehabilitation in cognitively impaired patients: Comprehensive assessment and tailored interventions. J Am Med Dir Assoc 2011, 12:395-397.
18. Morley J.E. Antipsychotics and dementia: A time for restraint. J Am Med Dir Assoc 2012, 13:761-763.
19. Nakanishi M., Hattori K., Nakashima T., Sawamura K. Priority for elderly persons with behavioral and psychological symptoms of dementia on waiting lists for placement in nursing homes in Japan: Do nursing homes change priorities based on their own guidelines?. J Am Med Dir Assoc 2012, 13:794-799.
20. Locca J.F., Büla C.J., Zumbach S., Bugnon O. Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: Development of practice recommendations in a Swiss canton. J Am Med Dir Assoc 2008, 9:439-448.